Prosecution Insights
Last updated: August 15, 2026

Tempus AI Inc.

28 pending office actions • 14 art units • 22 examiners • 0 of 28 (0%) have an AI response strategy ready • 18 patents granted in the last 365 days

Portfolio Summary

28
Total Pending OAs
11
Non-Final OAs
16
Final Rejections
1
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 9 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

4
Overdue
2
Due this week
3
Due this month
0
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 9 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (4)Due ≤ 7 days (2)Due ≤ 30 days (3)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

20
Hard (71%)
5
Medium (18%)
3
Easy (11%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 only3 (11%)
§101 + other17 (61%)
§103 only5 (18%)
§112 only2 (7%)
Double-patenting only1 (4%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

9
Life Sciences
32% of docket
2
Information Tech
7% of docket
3
Communications
11% of docket
0
Semiconductors
0% of docket
12
Mechanical / Eng
43% of docket
2
Business / Other
7% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

280 h
Manual time on pending OAs
56 h
Time saved (low, 20%)
98 h
Time saved (mid, 35%)
2.5 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
MINCHELLA, KAITLYN L 4 26.9% +22.1%
VARNDELL, ROSS E 2 84.7% +13.2%
SASS, KIMBERLY A. 2 53.0% +53.3%
LIN, JERRY 2 72.3% +15.0%
MOSER, BRUCE M 1 84.2% +19.9%
LAGOY, KYRA RAND 1 11.8% -14.3%
COLEMAN, CHARLES P. 1 16.1% +19.1%
SZUMNY, JONATHON A 1 56.8% +58.1%
HIGGS, STELLA EUN 1 38.7% +35.2%
AUGER, NOAH ANDREW 1 34.7% +40.8%

Quick Wins (1)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
19067139 ARTIFICIAL INTELLIGENCE ENGINE FOR DIRECTED HYPOTHESIS GENERATION AND RANKING MOSER, BRUCE M 19d overdue

Hard Cases (23)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18398649 SYSTEMS AND METHODS FOR PREDICTING PATIENT RECRUITMENT AT CLINICAL SITES MERCHANT, SHAHID R 111d overdue
18635663 SYSTEMS AND METHODS FOR PREDICTING CLINICAL RESPONSE ILAGAN, VINCENT CAESAR 99d overdue
16888357 PAN-CANCER MODEL TO PREDICT THE PD-L1 STATUS OF A CANCER CELL SAMPLE USING RNA EXPRESSION DATA AND OTHER PATIENT DATA MINCHELLA, KAITLYN L 46d overdue
18433240 DETERMINING BIOMARKERS FROM HISTOPATHOLOGY SLIDE IMAGES VARNDELL, ROSS E 5d
18544092 SYSTEMS, METHODS, AND ARTICLES FOR STRUCTURED ELECTRONIC HEALTH RECORD IMPUTATION USING DIAGNOSTIC TEMPORAL WINDOW COVINGTON, AMANDA R 7d
16889779 SYSTEMS AND METHODS OF CLINICAL TRIAL EVALUATION COBANOGLU, DILEK B 16d
16732229 TRANSCRIPTOME DECONVOLUTION OF METASTATIC TISSUE SAMPLES MINCHELLA, KAITLYN L 28d
19360756 Determining Biomarkers from Histopathology Slide Images VARNDELL, ROSS E

Interview Candidates (15)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
16888357 PAN-CANCER MODEL TO PREDICT THE PD-L1 STATUS OF A CANCER CELL SAMPLE USING RNA EXPRESSION DATA AND OTHER PATIENT DATA MINCHELLA, KAITLYN L 46d overdue
19067139 ARTIFICIAL INTELLIGENCE ENGINE FOR DIRECTED HYPOTHESIS GENERATION AND RANKING MOSER, BRUCE M 19d overdue
18433240 DETERMINING BIOMARKERS FROM HISTOPATHOLOGY SLIDE IMAGES VARNDELL, ROSS E 5d
16732229 TRANSCRIPTOME DECONVOLUTION OF METASTATIC TISSUE SAMPLES MINCHELLA, KAITLYN L 28d
19360756 Determining Biomarkers from Histopathology Slide Images VARNDELL, ROSS E
18949724 METHODS AND SYSTEMS FOR STRATIFYING PATIENT CANCER RISK USING COMPUTATIONAL ONCOLOGY AND MOLECULAR DATA COLEMAN, CHARLES P.
18936981 SYSTEMS AND METHODS FOR INTERROGATING CLINICAL DOCUMENTS FOR CHARACTERISTIC DATA SZUMNY, JONATHON A
18789091 COMPUTER SYSTEMS FOR CHECK POINT IDENTIFICATION HIGGS, STELLA EUN

Top Art Units

Art UnitApps
1685 6
3686 5
2674 2
3681 2
3684 2
2154 1
3685 1
3683 1
1687 1
2488 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19360756 Determining Biomarkers from Histopathology Slide Images VARNDELL, ROSS E 2674 §101§103Other Final Rejection Pending Oct 16, 2025
19067139 ARTIFICIAL INTELLIGENCE ENGINE FOR DIRECTED HYPOTHESIS GENERATION AND RANKING MOSER, BRUCE M 2154 §103 Final Rejection 19d overdue Pending Feb 28, 2025
19042728 DETECTING CARDIOVASCULAR CONDITION FROM ELECTROCARDIOGRAM DATA USING ENSEMBLE OF ARTIFICIAL INTELLIGENCE MODELS LAGOY, KYRA RAND 3685 §103 Non-Final OA Pending Jan 31, 2025
18949724 METHODS AND SYSTEMS FOR STRATIFYING PATIENT CANCER RISK USING COMPUTATIONAL ONCOLOGY AND MOLECULAR DATA COLEMAN, CHARLES P. 3683 §101§103 Non-Final OA Pending Nov 15, 2024
18936981 SYSTEMS AND METHODS FOR INTERROGATING CLINICAL DOCUMENTS FOR CHARACTERISTIC DATA SZUMNY, JONATHON A 3686 §112 Final Rejection Pending Nov 04, 2024
18789091 COMPUTER SYSTEMS FOR CHECK POINT IDENTIFICATION HIGGS, STELLA EUN 3681 §101§103 Final Rejection Pending Jul 30, 2024
18679338 Systems and Methods for Deploying a Machine-Learning Model for Performing a Specific Clinical Task SASS, KIMBERLY A. 3686 §101§103 Final Rejection Pending May 30, 2024
18679344 Systems and Methods for Providing Third-Party Interactions with a Set of Task-Specific Components SASS, KIMBERLY A. 3686 §101§103 Final Rejection Pending May 30, 2024
18674017 SYSTEMS AND METHODS FOR MULTI-LABEL CANCER CLASSIFICATION AUGER, NOAH ANDREW 1687 §101§112 Final Rejection Pending May 24, 2024
18660213 DATA BASED CANCER RESEARCH AND TREATMENT SYSTEMS AND METHODS NEWTON, CHAD A 3681 §101§102§103 Final Rejection Pending May 09, 2024
18651561 ATTENTION-BASED METHODS AND SYSTEMS FOR IMPROVING QUALITY CONTROL OF WHOLE-SLIDE IMAGE PREDICTIONS PERUNGAVOOR, SATHYANARAYA V 2488 §112 Final Rejection 8d Pending Apr 30, 2024
18635663 SYSTEMS AND METHODS FOR PREDICTING CLINICAL RESPONSE ILAGAN, VINCENT CAESAR 3686 §101§103§112 Final Rejection 99d overdue Pending Apr 15, 2024
18607389 DISTRIBUTING DIAGNOSTIC PREDICTION MODELS TO, BAOQUOC N §101§103 Non-Final OA Pending Mar 15, 2024
18592272 SYSTEMS AND METHODS FOR GENERATING A RADIOLOGY REPORT NGUYEN, PHU K 2616 §103 Final Rejection Pending Feb 29, 2024
18433240 DETERMINING BIOMARKERS FROM HISTOPATHOLOGY SLIDE IMAGES VARNDELL, ROSS E 2674 §101§102§103§112DPOther Final Rejection 5d Pending Feb 05, 2024
18398649 SYSTEMS AND METHODS FOR PREDICTING PATIENT RECRUITMENT AT CLINICAL SITES MERCHANT, SHAHID R 3684 §101 Non-Final OA 111d overdue Pending Dec 28, 2023
18544092 SYSTEMS, METHODS, AND ARTICLES FOR STRUCTURED ELECTRONIC HEALTH RECORD IMPUTATION USING DIAGNOSTIC TEMPORAL WINDOW COVINGTON, AMANDA R 3686 §101 Non-Final OA 7d Pending Dec 18, 2023
18222324 TRANSFORMING UNSTRUCTURED PATIENT DATA STREAMS USING SCHEMA MAPPING AND CONCEPT MAPPING WITH QUALITY TESTING AND USER FEEDBACK MECHANISMS LEE, ANDREW ELDRIDGE 3684 §101§103 Non-Final OA Pending Jul 14, 2023
18298371 DATA BASED CANCER RESEARCH AND TREATMENT SYSTEMS AND METHODS SABOUR, GHAZAL §101§103§112DP Non-Final OA Pending Apr 11, 2023
17968509 Detection of Human Leukocyte Antigen Loss of Heterozygosity LIN, JERRY 1685 §101§103DP Non-Final OA Pending Oct 18, 2022
17902558 EXECUTION AND COMMUNICATION PROTOCOL FOR ALGORITHMIC PROCESSING IN A DIAGNOSTICS SYSTEM STUBBS, JOHN THOMAS 1686 §101§102§103 Non-Final OA Pending Sep 02, 2022
17816345 Detection of Genetic Variants in Human Leukocyte Antigen Genes LIN, JERRY 1685 §101§112 Non-Final OA Pending Jul 29, 2022
17857901 LARGE SCALE ORGANOID ANALYSIS NGUYEN, NAM P 1678 DP Non-Final OA Pending Jul 05, 2022
17571412 SYSTEMS AND METHODS FOR JOINT LOW-COVERAGE WHOLE GENOME SEQUENCING AND WHOLE EXOME SEQUENCING INFERENCE OF COPY NUMBER VARIATION FOR CLINICAL DIAGNOSTICS MINCHELLA, KAITLYN L 1685 §103 Final Rejection Pending Jan 07, 2022
17150992 SYSTEMS AND METHODS FOR MULTI-LABEL CANCER CLASSIFICATION MINCHELLA, KAITLYN L 1685 §103 Final Rejection Pending Jan 15, 2021
16889779 SYSTEMS AND METHODS OF CLINICAL TRIAL EVALUATION COBANOGLU, DILEK B 3687 §101 Non-Final OA 16d Pending Jun 01, 2020
16888357 PAN-CANCER MODEL TO PREDICT THE PD-L1 STATUS OF A CANCER CELL SAMPLE USING RNA EXPRESSION DATA AND OTHER PATIENT DATA MINCHELLA, KAITLYN L 1685 §101§103§112 Final Rejection 46d overdue Pending May 29, 2020
16732229 TRANSCRIPTOME DECONVOLUTION OF METASTATIC TISSUE SAMPLES MINCHELLA, KAITLYN L 1685 §101§103 Final Rejection 28d Pending Dec 31, 2019

Managing Tempus AI Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month